Project Grant HT94252410173
Award Date
9/15/24
Completion Date
9/14/27
Dollars Obligated
$909K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
College Station, TX 77843, USA
Similar Awards
The U.S. Department of Defense, Defense Health Agency has awarded a $918,000 Project Grant to the Texas A&M University System Health Science Center to conduct research on "INNATE AND ADAPTIVE IMMUNE MECHANISMS OF CD74 IN POST-TRAUMATIC EPILEPSY". This 3-year grant, running from September 15, 2024 to September 14, 2027, is funded under the Military Medical Research and Development (CFDA 12.420) program. The project aims to investigate basic and translational research on the role...
The Department of the Army Medical Command awarded $745,304 to Texas A&M University Health Science Center under the Military Medical Research and Development program (CFDA 12.420) to support the project "Epigenetic Therapy for Post-Traumatic Epilepsy" from September 30, 2022 through September 29, 2025. The project aims to develop innovative medical solutions for traumatic brain injury through basic, applied, and advanced biomedical research investigating epigenetic approaches to...
The federal Project Grant award of $1,001,000.00 was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on September 30, 2025, supports ENDOCANNABINOID MECHANISMS OF POST-TRAUMATIC EPILEPSY research conducted by the Texas A & M University System Health Science Center (TAMU HSC) in College Station, TX. The research aims to advance understanding of medical solutions for addressing post-traumatic...
The Defense Health Agency has awarded a $760,844.00 Project Grant to the Texas A&M University System Health Science Center to conduct research under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, awarded on September 15, 2023 with a completion date of September 14, 2026, will fund research titled "Targeting the MIF/CD74 Immune Axis to Treat GWI Astrocyte, Neuronal, and Cognitive Dysfunction." This research aims to investigate medical...
This $839,745 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) aims to improve care and outcomes for veterans with post-traumatic epilepsy. The grant was awarded to Baylor College of Medicine, a private health sciences university in Houston, Texas, to conduct research and develop new treatments in this area over the 3-year performance period from May 1, 2024 to April 30, 2027. As a leading academic medical center, Baylor...
The Defense Health Agency awarded a $999,784 Project Grant to the Texas A&M University System Health Science Center (TAMU HSC) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from February 1, 2025 to January 31, 2028, will support TAMU HSC's research on "Circadian Dysregulation as a Risk Factor for Age-Related Cognitive Impairment." The research aims to investigate innovative approaches to addressing...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program provides $1,072,500.00 to Tufts University School of Medicine to conduct research aimed at "REDUCING POST-TRAUMATIC EPILEPSY BY BLOCKING MIAT SIGNALING IN PARVALBUMIN-POSITIVE INHIBITORY GABAERGIC INTERNEURONS." The award period runs from April 1, 2025 to March 31, 2028. As a leading academic medical institution, Tufts...
The U.S. Department of the Army Medical Command awarded a $422,299 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Texas A & M University System Health Science Center (TAMU HSC) on February 1, 2025. The grant supports TAMU HSC's research to inhibit renal lymphatic expansion in order to mitigate nephrotic syndrome, with a planned completion date of January 31, 2027. The grant enables TAMU HSC to conduct advanced biomedical research and develop...
The Department of the Army Medical Command awarded a $3,099,990 project grant to the Western Institute For Veterans Research under the Military Medical Research and Development program (CFDA 12.420). The grant will fund the MILITARY INJURIES - UNDERSTANDING POST-TRAUMATIC EPILEPSY (MINUTE): BIOINFORMATICS WITH BIG DATA TO EXAMINE MULTIMODAL PTE BIOMARKERS project from September 30, 2021 through September 29, 2025. The project aims to utilize bioinformatics and big data approaches to examine...
The federal Project Grant award of $488,086.00, with a performance period from May 1, 2025 to April 30, 2027, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public, with a particular emphasis on conditions relevant to military personnel and veterans. The award was granted to The Henry M....